Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 12.06.2026 FKUD IE00BD9N0445  121,463.00 GBP   3,666,204.48   30.184  ...

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Grail, Inc. (GRAL) Shareholders to Inquire About Securities Fraud Class Action...

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Zillow Group, Inc. (Z, ZG) Shareholders To Inquire About Securities Fraud Class Action...

CHICAGO & TAIPEI, Taiwan--(BUSINESS WIRE)--The Taiwan Excellence Pavilion at Automate 2026 features 23 Taiwanese companies showcasing edge AI, robotics and smart manufacturing technology...

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 12 June 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Compan...

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 12 June 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and toge...

CALGARY, Alberta--(BUSINESS WIRE)--CES Energy Solutions Corp. Announces Closing of Senior Unsecured Notes Offering...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective agonist, improved daily functioning as well as cognitive and sleep-related symptoms associated with narcolepsy type 1 (NT1).1,2,3 Oveporexton is designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. These data, along with previ...

FAIRVIEW, Texas--(BUSINESS WIRE)--The legal battle is over. The moral one is just beginning. The Town of Fairview, Texas, population approximately 11,000 and annual budget $13 million, has launched FairviewSpeaks, a community campaign with a simple, moral request: The Church of Jesus Christ of Latter-day Saints, with $91 billion in operating assets and $231 billion in investments, should voluntarily lower the steeple of its planned Fairview Texas Temple from 120 feet to 100 feet the height Fair...

LOS ANGELES--(BUSINESS WIRE)--LA Kings and ROWI Teen & Parent Wellness Centers Partner to Advance Youth Mental Health and Family Wellness...